Geron | GERN - Gross Profit On Sales


Geron reported $50.14M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Amgen USD 5.87B 1.02B Mar/2026
Bio Techne USD 222.15M 13.86M Jun/2026
Cassava Sciences USD -3.96M 1.16M Sep/2025
Cytokinetics USD 23.03M 3.84M Jun/2026
Exelixis USD 608.03M 17.17M Jun/2026
Genmab DKK 1.07B 240M Jun/2026
Geron USD 50.14M 3.44M Mar/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
Incyte USD 1.57B 400.89M Jun/2026
MacroGenics USD 11.24M 19.87M Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Novavax USD 125.04M 76.09M Dec/2025